Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMS | ASMB | SLGL | ||
| Company | Adamas Pharma | Assembly Biosciences | Sol-Gel Technologies Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.24 | 29.52 | 76.00 | ||
| High | 8.25 | 30.05 | 77.99 | ||
| Low | 8.18 | 29.20 | 74.41 | ||
| Latest | 8.22 | 29.41 | 76.49 | ||
| Change | +0.06 | +0.17 | +2.08 | ||
| % Change | +0.74% | +0.58% | +2.80% | ||
| Volume | 3,151,400 | 44,250 | 28,466 | ||
| 20-Day Average Volume | 834,440 | 81,216 | 60,328 | ||
| Previous Close | 8.16 | 29.24 | 74.41 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.16 | 28.56 | 76.03 | ||
| 20-Day Raw Stochastic | 86.36% | 74.77% | 46.45% | ||
| 20-Day Relative Strength | 73.46 | 52.92 | 50.45 | ||
| Weighted Alpha | +22.54 | +106.95 | +486.73 | ||
| Today's Opinion | 100% Buy | 32% Buy | 56% Buy | ||
| Previous Opinion | 96% Buy | 16% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 16% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.86% since 11/16/21 | +3.79% since 04/07/26 | +7.72% since 04/07/26 | ||
| Low | 8.15 on 11/17/21 | 28.26 on 04/10/26 | 71.15 on 04/09/26 | ||
| High | 8.25 on 11/23/21 | 30.72 on 04/10/26 | 77.99 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | +2.62% since 10/22/21 | +5.32% since 03/13/26 | -8.78% since 03/13/26 | ||
| Low | 8.00 on 10/25/21 | 26.32 on 03/30/26 | 61.92 on 03/23/26 | ||
| High | 8.25 on 11/23/21 | 30.72 on 04/10/26 | 93.53 on 03/24/26 | ||
| 3-Month | |||||
| %Chg | +77.54% since 08/23/21 | -7.58% since 01/14/26 | +13.00% since 01/14/26 | ||
| Low | 4.41 on 08/27/21 | 24.67 on 01/30/26 | 48.26 on 01/23/26 | ||
| High | 8.25 on 11/23/21 | 32.31 on 01/15/26 | 97.97 on 03/03/26 | ||
| 6-Month | |||||
| %Chg | +57.47% since 05/21/21 | +4.30% since 10/14/25 | +92.70% since 10/14/25 | ||
| Low | 4.02 on 08/16/21 | 24.67 on 01/30/26 | 28.81 on 11/13/25 | ||
| High | 8.25 on 11/23/21 | 39.71 on 11/20/25 | 97.97 on 03/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 376,369 | 463,834 | 209,085 | ||
| Shares Outstanding, K | 45,787 | 15,863 | 2,810 | ||
| Annual Sales | 74,460,000 | 72,300,000 | 19,390,000 | ||
| Annual Net Income | -57,400,000 | -6,120,000 | -6,130,000 | ||
| Last Quarter Sales | 25,900,000 | 42,470,000 | 700,000 | ||
| Last Quarter Net Income | -19,520,000 | 22,090,000 | -2,990,000 | ||
| 60-Month Beta | 2.82 | 1.15 | 1.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/10/21 | 2.48 on 03/19/26 | -1.07 on 03/19/26 | ||
| Latest Earnings Date | 02/22/22 | 05/14/26 | 05/22/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||